GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
910
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. GRAIL Inc. market cap is $4.46B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. GRAIL Inc. 52 week high is $166.48 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GRAIL Inc. 52 week low is $41.50 as of November 22, 2026.
GRAIL Inc. stock price today is $99.25.
GRAIL Inc. stock price yesterday was $104.84.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. GRAIL Inc.'s P/E ratio is -10.45.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. GRAIL Inc. P/B ratio is 1.8104.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. GRAIL Inc. 50-day moving average is $123.97.